Jan Stach

Title: Jan Stach - Innovator in Pharmaceutical Manufacturing

Introduction

Jan Stach is a notable inventor based in Prague, Czech Republic. He has made significant contributions to the field of pharmaceutical manufacturing. His innovative work has led to the development of a unique method for producing a specific amorphous form of a pharmaceutical compound.

Latest Patents

Jan Stach holds a patent for a method of manufacturing an amorphous form of the hemi-calcium salt of (3R,5R) 7-3-phenyl-4-phenylcarbamoyl-2-(4-fluorophenyl)-5-isopropyl-pyrrol-1-yll-3,5-dihydroxyheptanoic acid, commonly known as atorvastatin. This patent outlines a process that allows for the conversion of a starting acid or its salt into the hemi-calcium salt without isolating intermediates. The method involves treating the compound with calcium salts or calcium hydroxide, leading to the precipitation of the desired product.

Career Highlights

Jan Stach is currently employed at Zentiva, a prominent pharmaceutical company. His work at Zentiva has focused on innovative methods that enhance the efficiency and effectiveness of drug manufacturing processes. His expertise in this area has positioned him as a valuable asset to the company.

Collaborations

Jan collaborates closely with his coworker, Stanislav Radl. Together, they work on advancing pharmaceutical technologies and improving manufacturing techniques.

Conclusion

Jan Stach's contributions to pharmaceutical manufacturing through his innovative patent demonstrate his commitment to advancing the field. His work continues to impact the industry positively, showcasing the importance of innovation in healthcare.